The EPO published application EP3954337A1 for a cruciate replacing artificial knee on March 25, 2026. The patent covers A61F 2/38 (knee joint prostheses), A61F 2/30 (joint component prostheses), and A61F 2/08 (ligament replacement devices). Inventor and applicant is Jonathan P. Garino. The application designates 31 European states for patent protection including major markets such as Germany, France, UK, Italy, Spain, Netherlands, Poland, Sweden, and Austria.

Medical device manufacturers developing knee prostheses or ligament replacement systems should review the patent claims to assess potential freedom-to-operate implications. Healthcare providers and patients seeking prosthetic knee replacements may have access to this technology upon commercialization. The patent does not impose compliance deadlines or penalties—it grants exclusionary rights rather than regulatory obligations.